MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-14-2026
Moleculin Biotech Total Shareholders Equity 2011-2026 | MBRX
Annual Total Shareholders Equity Moleculin Biotech
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 M | 11.2 M | 30.9 M | 52.2 M | 79 M | 17.8 M | 15.6 M | 14.3 M | 17.1 M | 15 M | -745 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 79 M | -745 K | 24.3 M |
Quarterly Total Shareholders Equity Moleculin Biotech
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.2 M | -26.9 M | -7.16 M | 42 K | 11.2 M | 17.4 M | 17.7 M | 21.6 M | 26.1 M | 35.1 M | 40.3 M | 45.7 M | 52.2 M | 58.4 M | 66.4 M | 72.7 M | 79 M | 81.3 M | 84.7 M | 88.5 M | 17.8 M | 17.8 M | 17.8 M | 17.8 M | 15.6 M | 15.6 M | 15.6 M | 15.6 M | 14.3 M | 14.3 M | 14.3 M | 14.3 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 15 M | 15 M | 15 M | 15 M | -745 K | -745 K | -745 K | -745 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 88.5 M | -26.9 M | 24.9 M |
Total Shareholders Equity of other stocks in the Biotechnology industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
FSD Pharma
HUGE
|
5.1 M | - | 5743.5 % | $ 69.7 M |  Canada |
 |
MorphoSys AG
MOR
|
621 M | - | 2.43 % | $ 254 M |  Germany |
 |
Happiness Biotech Group Limited
HAPP
|
24.3 M | - | 1.35 % | $ 17.8 M |  China |
 |
AgeX Therapeutics
AGE
|
-37 K | - | -10.17 % | $ 12.2 K |  USA |
 |
Coherus BioSciences
CHRS
|
61 M | $ 1.69 | 2.74 % | $ 198 M | USA |
 |
I-Mab
IMAB
|
1.72 B | - | - | $ 866 M | China |
 |
Celldex Therapeutics
CLDX
|
527 M | $ 31.56 | 2.29 % | $ 2.1 B | USA |
 |
Biophytis SA
BPTS
|
2.27 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-16.2 M | - | 2.54 % | $ 160 B | France |
 |
BioNTech SE
BNTX
|
19.2 B | $ 93.5 | 1.35 % | $ 22.6 B | Germany |
 |
CRISPR Therapeutics AG
CRSP
|
1.92 B | $ 53.73 | 4.15 % | $ 4.83 B |  Schweiz |
 |
AstraZeneca PLC
AZN
|
48.7 B | - | - | $ 96.9 B |  Britain |
 |
Athira Pharma
ATHA
|
27.8 M | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
-14.6 M | - | 0.74 % | $ 768 M |  Israel |
 |
Compugen Ltd.
CGEN
|
103 M | $ 2.74 | 3.46 % | $ 256 M | Israel |
 |
Abcam plc
ABCM
|
727 M | - | - | $ 4.9 B | Britain |
 |
Galera Therapeutics
GRTX
|
3.97 M | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
11.4 M | - | -18.52 % | $ 27.3 M | Britain |
|
Enlivex Therapeutics Ltd.
ENLV
|
1.93 B | $ 0.76 | 11.14 % | $ 34.7 M | Israel |
 |
Esperion Therapeutics
ESPR
|
-302 M | $ 3.13 | 0.32 % | $ 651 M | USA |
 |
Eton Pharmaceuticals
ETON
|
26.2 M | $ 32.33 | 3.32 % | $ 870 M | USA |
 |
Affimed N.V.
AFMD
|
57.8 M | - | -34.95 % | $ 21.5 M | Germany |
|
Forte Biosciences
FBRX
|
61 M | $ 21.58 | -1.64 % | $ 279 M | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
69.5 M | - | - | $ 231 M | USA |
 |
Celyad Oncology SA
CYAD
|
4.32 M | - | - | $ 12.5 M |  Belgium |
 |
Berkeley Lights
BLI
|
142 M | - | -7.31 % | $ 87 M | USA |
 |
Galectin Therapeutics
GALT
|
-128 M | $ 2.71 | -2.87 % | $ 173 M | USA |
 |
Generation Bio Co.
GBIO
|
86.2 M | - | - | $ 344 M | USA |
 |
IMV
IMV
|
-6.6 M | - | - | $ 13.1 M | Canada |
 |
Akero Therapeutics
AKRO
|
750 M | - | - | $ 3.67 B | USA |
 |
Akouos
AKUS
|
234 M | - | 0.23 % | $ 488 M | USA |
 |
Grifols, S.A.
GRFS
|
8.61 B | $ 8.05 | 0.44 % | $ 5.47 B |  Spain |
 |
Ayala Pharmaceuticals
AYLA
|
-1.1 M | - | - | $ 7.46 M | Israel |
 |
Hutchison China MediTech Limited
HCM
|
1.24 B | $ 11.68 | -0.6 % | $ 10 B | China |
 |
Heron Therapeutics
HRTX
|
14.3 M | $ 0.91 | 3.18 % | $ 152 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
6.84 M | - | -4.36 % | $ 27 M | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
52.4 M | - | - | $ 384 M | Britain |
 |
ImmuCell Corporation
ICCC
|
27.1 M | $ 10.49 | -0.1 % | $ 94.7 M | USA |
 |
Gracell Biotechnologies
GRCL
|
1.38 B | - | - | $ 3.37 B | China |
 |
Anika Therapeutics
ANIK
|
143 M | $ 14.72 | -1.12 % | $ 211 M | USA |
 |
Advaxis
ADXS
|
-24.4 M | - | -9.65 % | $ 45.9 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
715 M | - | - | $ 1.01 B | USA |
 |
CureVac N.V.
CVAC
|
688 M | - | - | $ 867 M | Germany |
 |
Applied Genetic Technologies Corporation
AGTC
|
29.5 M | - | - | $ 26.5 M | USA |
 |
AIkido Pharma
AIKI
|
69.4 M | - | 1.93 % | $ 17.4 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
5.59 M | $ 3.35 | -2.62 % | $ 5.51 M | Israel |